ClinConnect ClinConnect Logo
Search / Trial NCT01967121

Compex Use With Delayed Onset Muscle Soreness: A Comparison to Other Methods

Launched by MICHIGAN STATE UNIVERSITY · Oct 17, 2013

Trial Information

Current as of April 25, 2025

Completed

Keywords

Compex, Ice

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • The studied population will be composed of 45 physically active college students between the ages of 18-30 years old.
  • Inclusionary criteria will be participation in a physical activity as defined by the ACSM, which can be a mixture of moderate (i.e., sufficient to raise the heart rate and begin to sweat) and vigorous (i.e., breathing hard and fast with a rapidly rising heart rate) intensity aerobic activity and muscle strengthening (i.e., weights lifted to the point where anther repetition cannot be completed without help) activities two or more time per week (ACSM, 2011.)
  • Exclusion Criteria:
  • Exclusionary criteria will be surgery within the last six months requiring immobilization for more than four weeks, discomfort performing intense physical activity, diseases like muscular dystrophy that predispose muscular damage beyond reasonable levels resulting from physical activity, and current injury of the knees or hips.

About Michigan State University

Michigan State University (MSU) is a leading public research institution dedicated to advancing knowledge and improving health outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, MSU integrates cutting-edge research methodologies and expert faculty across various fields to address pressing health challenges. The university's commitment to ethical research practices and participant safety ensures that all clinical trials are conducted with the highest standards of integrity and compliance. By fostering a dynamic environment for scientific inquiry, MSU aims to translate research findings into practical solutions that enhance patient care and contribute to the broader healthcare community.

Locations

East Lansing, Michigan, United States

Patients applied

0 patients applied

Trial Officials

Tracey Covassin, PhD

Principal Investigator

Michigan State University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials